 Enveric Biosciences NASDAQ:ENVB announced that Bob Dagher will be joining the company as its chief medical officer. The psychedelic company said that Dagher brings over 20 years of experience working in clinical development in the pharmaceutical industry for both small and large pharmaceutical companies and as a board-certified physician from the American Board of neurology and psychiatry. 